Cargando…
Rituximab or plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis after kidney transplantation: A systematic review and meta-analysis
BACKGROUND: Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases leading to renal failure. FSGS has a high risk of recurrence after kidney transplantation. Prevention of recurrent FSGS using rituximab and/or plasmapheresis has been evaluated in multiple small studi...
Autores principales: | Boonpheng, Boonphiphop, Hansrivijit, Panupong, Thongprayoon, Charat, Mao, Shennen A, Vaitla, Pradeep K, Bathini, Tarun, Choudhury, Avishek, Kaewput, Wisit, Mao, Michael A, Cheungpasitporn, Wisit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291000/ https://www.ncbi.nlm.nih.gov/pubmed/34316454 http://dx.doi.org/10.5500/wjt.v11.i7.303 |
Ejemplares similares
-
Hepatitis E in solid organ transplant recipients: A systematic review and meta-analysis
por: Hansrivijit, Panupong, et al.
Publicado: (2021) -
Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis
por: Hansrivijit, Panupong, et al.
Publicado: (2020) -
Proton pump inhibitors and adverse effects in kidney transplant recipients: A meta-analysis
por: Boonpheng, Boonphiphop, et al.
Publicado: (2019) -
Thrombotic Microangiopathy among Hospitalized Patients with Systemic Lupus Erythematosus in the United States
por: Pivovarova, Aleksandra I., et al.
Publicado: (2020) -
Is It Time for Machine Learning Algorithms to Predict the Risk of Kidney Failure in Patients with Chronic Kidney Disease?
por: Thongprayoon, Charat, et al.
Publicado: (2021)